Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 303-323

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-08 ,pp. : 837-857

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyltransferase inhibitors:a cell signalling approach to the design of efficacious anticancer agents

By Sebolt-Leopold J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents

By  

Current Drug Targets, Vol. 2, Iss. 1, 2001-03 ,pp. : 79-106

Bentham Science Publishers

Access to resources Recommend Favorite